OptiNose (NASDAQ: OPTN) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.58 million.

GUIDANCE:

OptiNose sees FY2024 revenue of $85-90 million, versus the consensus of $92.25 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.